Oasis Capital won IPO Zao Zhi Dao's "2022 Best Healthcare Investment Firm" award.

In 2022, IPO performance diverged across markets, but top investment firms continued to deliver exceptional results. To recap the year's capital markets, IPO Zaozhidao recently released its "2022 Top 100 IPO Investment Firms," "2022 Best Investment Firms," and "2022 Best IPO Service Providers" rankings.

Among them, Oasis Capital was named "2022 Best Healthcare Investment Firm."

The world changes endlessly, and noise is everywhere. Oasis Capital will continue to adhere to its "top-down" research approach, combining ecosystem entrepreneur experience to deliver sustained signals to companies over the long term. We remain committed to "demographic structure" and "technological innovation" as our entry points, focusing on technology-enabled services in healthcare and enterprise software, and making long-term investments in the most vital entrepreneurs. Celebrating Vitality.

Click "Read More" to view the complete rankings.

Oasis Capital is a new-generation venture capital firm in China, dedicated to discovering the country's most vital entrepreneurs over the next decade and growing alongside them to create long-term value. "Celebrating Vitality" is Oasis's vision and mission. This vitality represents both the direction of structural transformation in our era and the resilience and evolutionary force of entrepreneurs.

Oasis Capital focuses on early and growth-stage investments, with check sizes ranging from $3 million to $30 million, concentrating on technology-enabled services in healthcare and enterprise software to support China's technology-driven new services upgrade.